SUNPHARMA Sun Pharmaceuticals Industries Ltd Business Restructuring Announcement 2023 - Financial Results and Scheme of Arrangement Sun Pharmaceutical Industries Ltd. has announced their unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2023, as well as a composite scheme of arrangement for the amalgamation of five wholly-owned subsidiaries with the company and reclassification of general reserves into retained earnings..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sun Pharmaceuticals Industries Ltd